Key result
Crizotinib and chemotherapy shrink disseminated ALK-positive histiocytosis before fatal intracranial infection at 8 months.
Why the study?
ALK-positive histiocytosis is a rare disorder that can affect multiple systems, with only 10 cases previously reported invading the central nervous system.
Case Report (n=1)
No
ALK-positive histiocytosis can disseminate intracranially and should be considered in the differential diagnosis of suprasellar lesions in children, though treatment may be complicated by fatal infections.
Answers are grounded in this paper and cite their sources.
ALK-positive histiocytosis merits consideration in pediatric suprasellar differentials; this case extends sparse evidence on targeted therapy while underscoring infection risks.
Background: Anaplastic lymphoma kinase (ALK)-positive histiocytosis is a rare type of histiocytosis that could affect multiple systems in children and adults. 10 cases of ALK-positive histiocytosis invading the central nervous system (CNS) have been reported. Herein, we report a case of ALK-positive histiocytosis invading the central nervous system and lungs and the details of follow-up of tumor dynamic changes during treatment. Case Presentation: An 18-month-old boy was underweight and had slow growth of almost 3 months duration. The child could not stand and walk independently, and his language and intelligence development occurred later than those of his peers. Cranial magnetic resonance imaging revealed a giant suprasellar lesion with isosignal, measuring approximately 5.1× 3.6× 4.0 cm on T1-weighted imaging, with an obvious mass effect. Nodular, slightly low-signal shadows were also observed in the left temporal pole and left hippocampus, measuring approximately 1.0 cm × 0.7 cm× 0.5 cm and 0.9 cm× 0.8 cm × 0.5 cm on T1-weighted, respectively. The child underwent partial resection of the suprasellar lesion, and a diagnosis of ALK-positive histiocytosis was made histologically. Subsequently, the patient received chemotherapy (CHOP regimen) and anti-ALK therapy (crizotinib). The lesions were gradually shrinking without dissemination and the changes of intracranial and lung lesions were monitored with imaging during therapy. Unfortunately, the child died 8 months after the first surgery because of worsening intracranial infection. Conclusion: ALK-positive histiocytosis may involve the central nervous system and disseminate intracranially. ALK-positive histiocytosis should be considered for the differential diagnosis of suprasellar lesions.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2022) conducted a case report in ALK-positive histiocytosis (n=1). Partial resection, chemotherapy (CHOP regimen), and crizotinib was evaluated on Tumor dynamic changes and survival. An 18-month-old boy with cerebrum-disseminated ALK-positive histiocytosis experienced gradual tumor shrinkage with crizotinib and chemotherapy but died 8 months after surgery due to intracranial infection.
Synapse has enriched 10 related papers. Consider them for comparative context: